A multidimensional approach to improve care and outcomes for people with inflammatory breast cancer (IBC).
Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India All AYA OGS and ES cases treated at our institute ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results